Progress in the application of lipid hydrogel silver sulfate dressing and sucrose octasulfate dressing in diabetic foot ulcer

doi:10.3877/cma.j.issn.1673-9450.2024.03.015

Abstract

Abstract:

Diabetic foot ulcer (DFU) is a typical representative of chronic wounds, and helping to achieve complete healing of DFU has been a key concern for medical professionals. In recent years, promoting wound healing from the topic treatment of wounds has been a hot topic of research, and more and more wound dressings with different efficacy and composition are appearing in clinical treatment. This narrative review introduces the characteristics of common types of new dressings and focuses on the latest research on silver lipidocolloid dressing (TLC-Ag) and sucrose octasulfate impregnated dressing (TLC-NOSF) and the progress of their application in DFU treatment. It is believed that these two composite new functional dressings have great research value and broad application prospects, which provide new ideas for the selection of DFU dressings.

Key words: Diabetic foot, Ulcer, Chronic wound, Bandages, Hydrocolloid, Silver lipidocolloid dressing, Sucrose octasulfate

Li Yang, Wenying Li, Yuan Tian, Linxi Zhou, Wei Wang. Progress in the application of lipid hydrogel silver sulfate dressing and sucrose octasulfate dressing in diabetic foot ulcer[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(03): 271-275.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2024.03.015

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2024/V19/I03/271

References 51

[1]	王宁，鞠上．糖尿病足溃疡难愈合机制研究进展[J].中华烧伤与创面修复杂志，2022，38(11)：1085-1089.
[2]	Armstrong DG, Boulton AJM, Bus SA.Diabetic foot ulcers and their recurrence[J].N Engl J Med，2017，376(24)：2367-2375.
[3]	Ndosi M，Wright-Hughes A，Brown S，et al.Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study[J]. Diabet Med，235(1)：78-88.
[4]	许樟荣.学习国际糖尿病足工作组2019版糖尿病足临床指南，规范糖尿病足的诊治[J].中华糖尿病杂志，2021：13(8)：753-757.
[5]	Chen P，Vilorio NC，Dhatariya K，et al.Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update)[J].Diabetes Metab Res Rev. 2023：e3644.
[6]	张道英，杨燕玲，黄浩，等．糖尿病足病理机制与治疗方法研究进展[J].沈阳药科大学学报，2021，38(6)：636-642.
[7]	Afonso AC, Oliveira D, Saavedra MJ，et al.Biofilms in diabetic foot ulcers: impact, risk factors and control strategies[J].Int J Mol Sci，2021，22(15)：8278.
[8]	Dong J，Chen L，Zhang Y，et al.Mast cells in diabetes and diabetic wound healing[J].Adv Ther，Nov，2020，37(11)：4519-4537.
[9]	Theocharidis G，Thomas BE，Sarkar D，et al.Single cell transcriptomic landscape of diabetic foot ulcers[J].Nat Commun，2022，13(1)：181.
[10]	Darvishi S，Tavakoli S，Kharaziha M，et al.Advances in the sensing and treatment of wound biofilms[J].Angew Chem Int Ed Engl，2022，61(13)：e202112218.
[11]	杜鸣，刘佳霖，许鑫，等．糖尿病足溃疡与感染患者病原菌分布与合理抗菌药物的选用分析[J].现代预防医学，2018，45(4)：737-741.
[12]	Winter GD. Formation of the scab and the rate of epithelisation of superficial wounds in the skin of the young domestic pig[J].J Wound Care，1995，4(8)：366-367; discussion 368-371.
[13]	曹瑛，林钰敏，薛耀明. 糖尿病足溃疡创面愈合的现代敷料[J].中华糖尿病杂志，2021，13(5)：5.
[14]	李少杰，冯昱，胡安安，等．新型敷料在慢性创面愈合中的作用及研究进展[J]. 中国医疗美容，2022，12(12)：49-54.
[15]	Heyer K, Augustin M, Protz K，et al.Effectiveness of advanced versus conventional wound dressings on healing of chronic wounds: systematic review and meta-analysis[J].Dermatology，2013，226(2)：172-184.
[16]	Arampatzis AS, Kontogiannopoulos KN, Theodoridis K, et al. Electrospun wound dressings containing bioactive natural products: physico-chemical characterization and biological assessment[J]. Biomater Res，2021，25(1)：23.
[17]	Gaspar-Pintiliescu A，Stanciuc AM，Craciunescu O．Natural composite dressings based on collagen, gelatin and plant bioactive compounds for wound healing: a review[J].Int J Biol Macromol，2019，138：854-865.
[18]	White R，Cowan T，Glover D．Supporting evidence-based practice: a clinical review of TLC technology[J].Journal of Wound Care，2011，20：1-36.
[19]	Broussard KC, Powers JG.Wound dressings: selecting the most appropriate type[J].Am J Clin Dermatol，2013，14(6)：449-459.
[20]	Meaume S，Ourabah Z，Cartier H，et al.Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers[J]. J Wound Care，2005，14(7)：329-334.
[21]	Benbow M，Iosson G．A clinical evaluation of Urgotul to treat acute and chronic wounds[J].Br J Nurs，2004，13(2)：105-109.
[22]	毕然然，许玉华，王绵，等．住院患者中糖尿病足感染病原菌及相关因素分析[J]. 中华糖尿病杂志，2019，(12)：782-787.
[23]	Johani K，Malone M，Jensen S，et al.Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers[J].Int Wound J，2017，14(6)：1160-1169.
[24]	Bhatia E, Banerjee R．Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection[J].J Mater Chem B，2020，8(22)：4890-4898.
[25]	Tseng BS，Zhang W，Harrison JJ，et al.The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin[J].Environ Microbiol，2013，15(10)：2865-2878.
[26]	刘焕亮，王慧杰，袭著革．纳米银的抗菌原理及生物安全性研究进展[J]. 环境与健康杂志，2009，26(8)：736-739
[27]	Wang YC，Lee HC，Chen CL，et al.The effects of silver-releasing foam dressings on diabetic foot ulcer healing[J].J Clin Med，2021，10(7)：1495.
[28]	Jung WK, Koo HC, Kim KW，et al.Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli[J].Appl Environ Microbiol，2008，74(7)：2171-2178.
[29]	Percival SL，Bowler PG，Dolman J．Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model[J].Int Wound J，2007，4(2)：186-191.
[30]	朱磊.观察银离子藻酸盐敷料治疗糖尿病足溃疡(DFU)创面的疗效[J].实用糖尿病杂志，2021，17(1)：76-77.
[31]	王徐红，柳国斌，徐磊．纳米银敷料治疗糖尿病足溃疡的疗效与安全的研究进展[J].海南医学院学报，2023，29(9)：715-720.
[32]	沙薇薇，邵燕，续琴，等．糖尿病足溃疡的危险因素探讨及亲水性纤维含银敷料促进患者伤口愈合的临床对照研究[J].现代生物医学进展，2022，22(11)：2081-2085.
[33]	Bisson JF，Hidalgo-Lucas S，Bouschbacher M，et al.Effects of TLC-Ag dressings on skin inflammation[J].J Dermatol，2013，40(6)：463-470.
[34]	Lazareth I，Ourabah Z，Senet P，et al.Evaluation of a new silver foam dressing in patients with critically colonised venous leg ulcers[J].J Wound Care，2007，16(3)：129-132.
[35]	Domagalska D，Bobkiewicz A，Banasiewicz T，et al.UrgoTul^® Ag/Silver dressing as an intermediate layer in negative pressure wound therapy in patient with unhealing wound after laparotomies[J].Leczenie Ran，2020，17：147-150.
[36]	Dissemond J, Dietlein M, Neβeler I, et al. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study[J].J Wound Care，2020，29(3)：162-173.
[37]	Lützkendorf S, Grünerbel A, Dietlein M, et al. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study[J].J Wound Care，2022，31(5)：366-378.
[38]	周景祺，唐佳俊，管皓楠，等．银离子敷料在糖尿病合并慢性创面治疗中的应用价值[J].中华糖尿病杂志，2021，(6)：603-609.
[39]	Toriseva M, Kahari VM.Proteinases in cutaneous wound healing[J]. Cell Mol Life Sci，2009，66(2)：203-224.
[40]	Lobmann R, Ambrosch A, Schultz G, et al.Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients[J].Diabetologia，2002，45(7)：1011-1016.
[41]	朱平，严励．基质金属蛋白酶及其组织抑制剂与创面愈合研究进展[J].国际内科学杂志，2006，33(6)：249-252.
[42]	芮顺利，陈天怡，李伶，等．基质金属蛋白酶家族在糖尿病足溃疡愈合中的作用[J].中华糖尿病杂志，2020，(9)：749-752.
[43]	Schmutz JL, Meaume S, Fays S, et al.Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial[J].Int Wound J，2008，5(2)：172-182.
[44]	Armstrong DG, Cohen K, Courric S，et al.Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not[J].J Diabetes Sci Technol，2011，5(6)：1591-1595.
[45]	Richard JL, Martini J, Bonello Faraill MM, et al.Management of diabetic foot ulcers with a TLC-NOSF wound dressing[J].J Wound Care，2012，21(3)：142-147.
[46]	Edmonds M, Lazaro-Martinez JL, Alfayate-Garcia JM, et al.Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial[J].Lancet Diabetes Endocrinol，2018，6(3)：186-196.
[47]	Münter KC，Meaume S，Augustin M，et al.The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings[J].J Wound Care，2017，26(Sup2)：S4-S15.
[48]	Meaume S, Dompmartin A, Lok C, et al.Quality of life in patients with leg ulcers: results from Challenge, a double-blind randomised controlled trial[J].J Wound Care，2017，26(7)：368-379.
[49]	National institute for health and care excellence. UrgoStart for treating diabetic foot ulcers and leg ulcers[J]. Medical technologies guidance, 2019.
[50]	Arroyo Ana A, Alvarez Vázquez JC, Blasco García C, et al.[Cost-effectiveness of a TLC-NOSF polyurethane foam dressing][J]. Rev Enferm，2012，35(11)：27-32.
[51]	Wong NSQ，Tan AHM，Chan KS，et al.A prospective study on the efficacy of sequential treatment of technology lipido-colloid impregnated with silver and technology lipido-colloid nano-oligosaccharide factor in the management of venous leg ulcers[J]. Health Sci Rep，2023，6(8)：e1488.

Please choose a citation manager

Content to export